iTeos Therapeutics to Present at SVB Leerink 9th Annual Global Healthcare Conference
Cambridge, MA and Gosselies, Belgium – February 18, 2020 – iTeos Therapeutics SA, a privately-held biotechnology company developing innovative cancer immunotherapies, today announced that Michel Detheux, Ph.D., president and chief executive officer, will present at the upcoming SVB Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020 at 2:15 p.m. ET in New York, NY.
For further information, please contact:
Michel Detheux, CEO
Amber Fennell, Paul Kidwell, Matthew Neal and Sukaina Virji
Consilium Strategic Communications
+44 203 709 5700
Stern Investor Relations, Inc.
+1 212 362 1200